Durable Intracranial Response to Sacituzumab Tirumotecan in HER2-Negative Salivary Duct Carcinoma With High TROP2 Expression: A Case Report.

Chen GL, Tan B, Cao S, Liu X, Guo Y, Ji D

Open source

DOI
10.1002/cnr2.70676
Published
2026 Sep
Container
Cancer reports (Hoboken, N.J.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cnr2.70676,
  title = {Durable Intracranial Response to Sacituzumab Tirumotecan in HER2-Negative Salivary Duct Carcinoma With High TROP2 Expression: A Case Report.},
  author = {Chen GL and Tan B and Cao S and Liu X and Guo Y and Ji D},
  year = {2026},
  journal = {Cancer reports (Hoboken, N.J.)},
  doi = {10.1002/cnr2.70676},
  url = {https://doi.org/10.1002/cnr2.70676}
}

RIS

TY  - JOUR
TI  - Durable Intracranial Response to Sacituzumab Tirumotecan in HER2-Negative Salivary Duct Carcinoma With High TROP2 Expression: A Case Report.
AU  - Chen GL
AU  - Tan B
AU  - Cao S
AU  - Liu X
AU  - Guo Y
AU  - Ji D
PY  - 2026
JO  - Cancer reports (Hoboken, N.J.)
DO  - 10.1002/cnr2.70676
UR  - https://doi.org/10.1002/cnr2.70676
ER  - 

APA

GL, C., B, T., S, C., X, L., Y, G., & D, J. (2026). Durable Intracranial Response to Sacituzumab Tirumotecan in HER2-Negative Salivary Duct Carcinoma With High TROP2 Expression: A Case Report.. Cancer reports (Hoboken, N.J.). https://doi.org/10.1002/cnr2.70676

Source records